Can You Get COVID-19 Again? Replay our May 22 HDLive!

Follow Our Live Coverage of COVID-19 Developments

Side-by-Side Heart Aids Win Approval

To prevent 2nd attack or 2nd stroke

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

WEDNESDAY, June 25, 2003 (HealthDayNews) -- After a heart attack or stroke, doctors seeking to prevent a recurrence often prescribe a statin medication to keep blood cholesterol in check, and advise patients to take a low-dose aspirin each day to thin the blood and help prevent clotting.

On Wednesday, Bristol-Myers Squibb was given the green light from the U.S. Food and Drug Administration to package the two together.

The newly approved Pravigard PAC contains the company's Pravachol (pravastatin sodium) tablets and buffered aspirin -- co-packaged with each daily dose side by side. The Pravigard PAC, including various doses of the two drugs, is available only by prescription.

Pravigard shouldn't be taken by women who are pregnant or nursing or who may become pregnant; people with liver or kidney problems, asthma or nasal polyps; children under 18; or those who are allergic to anti-inflammatory drugs known as NSAIDs, the company says.

For more information about Pravachol, visit the National Library of Medicine. To learn more about aspirin and how it benefits the heart, check the Federal Citizen Information Center.


Last Updated: